← FDA DRUG APPROVALS

FDA ANDA · ANDA077336

METFORMIN HYDROCHLORIDE

Sponsor: SUN PHARM INDS (IN)

APPLICATION
ANDA077336
TYPE
ANDA
ORIGINAL APPROVAL
2006-02-09
LATEST ACTION
2019-03-01
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 500MG · TABLET, EXTENDED RELEASE · ORAL
METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2019-03-01Labeling · Supplement 15 · standardAP
2019-03-01Labeling · Supplement 12 · standardAP
2015-09-28Labeling · Supplement 7 · standardAP
2010-11-19Labeling · Supplement 4AP
2007-11-07Labeling · Supplement 1AP
2006-02-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →